Crossmark

Influence of angiotensin receptor and converting enzyme blockers therapy in the respiratory outcome of COVID-19 hospitalized patients

Crossref DOI link: https://doi.org/10.1016/j.medcle.2023.10.009

Published Print: 2024-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Lima, Felipe B. http://orcid.org/0000-0002-0221-6142
Muniz, Francisco Wilker Mustafa Gomes http://orcid.org/0000-0002-3945-1752
Meneses, Gdayllon C. http://orcid.org/0000-0002-0160-5728
Bezerra, Karine C. http://orcid.org/0000-0002-6691-7415
Moreira, Carolyne N. http://orcid.org/0009-0009-2044-0779
Aguiar, André P. http://orcid.org/0000-0002-7343-8068
Nascimento, José Carlos R. http://orcid.org/0000-0002-1490-2393
Veras de S. Freitas, Tainá http://orcid.org/0000-0002-4435-0614
de Bruin, Pedro Felipe C. http://orcid.org/0000-0001-9694-1523
Pereira, Eanes Delgado B. http://orcid.org/0000-0002-4414-3164
Daher, Elizabeth de F. http://orcid.org/0000-0003-4189-1738
Oriá, Reinaldo B. http://orcid.org/0000-0002-6914-5481
License Information

Text and Data Mining valid from 2024-02-01

stm-asf valid from 2024-02-01

stm-asf valid from 2024-02-01

stm-asf valid from 2024-02-01

stm-asf valid from 2024-02-01

stm-asf valid from 2024-02-01
More Information

This article is maintained by: Elsevier

Article Title: Influence of angiotensin receptor and converting enzyme blockers therapy in the respiratory outcome of COVID-19 hospitalized patients

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2023.10.009

Content Type: article

Copyright: © 2023 Elsevier España, S.L.U. All rights reserved.